Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Prohibits the state, participating ERISA, or any health plan from purchasing referenced drugs for a cost higher than the referenced rate.
Introduced
Feb 28, 2025
Last Action
Mar 6, 2025
Session
RI 2025
Sponsors
10 primary · 0 co
03/06/2025 Committee recommended measure be held for further study
02/28/2025 Introduced, referred to House Health & Human Services
02/28/2025 Scheduled for hearing and/or consideration (03/06/2025)